BFNH
BioForce Nanosciences Holdings, Inc.
Price Chart
Latest Quote
$1.32
+0.47 (+55.29%)
Current Price
| Previous Close | $0.85 |
| Open | $0.94 |
| Day High | $1.32 |
| Day Low | $0.94 |
| Volume | 1,520 |
Stock Information
| Shares Outstanding | 33.55M |
| Total Debt | $100K |
| Cash Equivalents | $6K |
| Net Income | $-459K |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Market Cap | $44.28M |
| EPS (TTM) | $-0.01 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $44.38M |
| Income | $-459K |
| Book/sh | $-0.02 |
| Cash/sh | $0.00 |
| Employees | 3 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.01 |
Returns & Margins
| ROA | -2942.44% |
Ownership
| Insider Ownership | 80.98% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -60.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 54.48 |
| ATR | nan |
| Shares Float | 8.49M |
| Volatility | -0.30 |
| Rel Volume | 1.57 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 5 Years | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $nan | 1,520 |
| 2026-06-03 | $0.79 | 4,000 |
| 2026-06-02 | $0.76 | 5,400 |
| 2026-06-01 | $0.85 | 200 |
| 2026-05-29 | $0.66 | 200 |
| 2026-05-28 | $0.81 | 100 |
| 2026-05-27 | $0.75 | 0 |
| 2026-05-26 | $0.75 | 600 |
| 2026-05-22 | $0.80 | 0 |
| 2026-05-21 | $0.80 | 0 |
| 2026-05-20 | $0.80 | 400 |
| 2026-05-19 | $0.55 | 0 |
| 2026-05-18 | $0.55 | 2,700 |
| 2026-05-15 | $0.87 | 700 |
| 2026-05-14 | $0.67 | 1,300 |
| 2026-05-13 | $0.55 | 1,400 |
| 2026-05-12 | $0.87 | 0 |
| 2026-05-11 | $0.87 | 0 |
| 2026-05-08 | $0.87 | 700 |
| 2026-05-07 | $0.89 | 100 |
| 2026-05-06 | $0.35 | 4,900 |
| 2026-05-05 | $0.90 | 0 |
About BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It offers private label products with distributors and manufacturing providers. The company also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.
đ° Latest News
No news articles available at the moment. Check back later for updates on BFNH.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $0 | $0 | $0 | $0 |
| Cost Of Revenue | $0 | $0 | $0 | $0 |
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $490,437 | $471,953 | $485,514 | $501,955 |
| Operating Expense | $490,437 | $471,953 | $485,514 | $501,955 |
| General And Administrative Expense | $490,437 | $471,953 | $485,514 | $501,955 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Normalized Income | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Net Income From Continuing And Discontinued Operation | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Net Income Common Stockholders | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Net Income | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Net Income Including Noncontrolling Interests | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Net Income Continuous Operations | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Pretax Income | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Operating Income | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $-0.02 | $-0.02 | $-0.02 | $-0.02 |
| Basic EPS | $-0.02 | $-0.02 | $-0.02 | $-0.02 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| EBITDA (Bullshit earnings) | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| EBIT | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Diluted Average Shares | $29,271,755 | $29,271,755 | $29,271,755 | $29,271,755 |
| Basic Average Shares | $29,271,755 | $29,271,755 | $29,271,755 | $29,271,755 |
| Diluted NI Availto Com Stockholders | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Selling General And Administration | $490,437 | $471,953 | $485,514 | $501,955 |
| Other Gand A | $67,437 | $48,953 | $62,514 | $78,955 |
| Salaries And Wages | $423,000 | $423,000 | $423,000 | $423,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-2,301,592 | $-1,819,230 | $-1,347,277 | $-861,863 |
| Total Assets | $862 | $638 | $734 | $11,145 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $862 | $638 | $734 | $11,145 |
| Cash Cash Equivalents And Short Term Investments | $862 | $638 | $734 | $11,105 |
| Cash And Cash Equivalents | $862 | $638 | $734 | $11,105 |
| Cash Financial | $862 | $638 | $734 | $11,105 |
| Prepaid Assets | - | - | $0 | $40 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,302,454 | $1,819,868 | $1,348,011 | $873,008 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $2,302,454 | $1,819,868 | $1,348,011 | $873,008 |
| Payables And Accrued Expenses | $282,937 | $223,351 | $174,494 | $122,491 |
| Payables | $282,937 | $223,351 | $174,494 | $122,491 |
| Accounts Payable | $8,836 | $2,649 | $398 | $6,313 |
| Equity | ||||
| Common Stock Equity | $-2,301,592 | $-1,819,230 | $-1,347,277 | $-861,863 |
| Total Equity Gross Minority Interest | $-2,301,592 | $-1,819,230 | $-1,347,277 | $-861,863 |
| Stockholders Equity | $-2,301,592 | $-1,819,230 | $-1,347,277 | $-861,863 |
| Retained Earnings | $-161,120,166 | $-160,629,729 | $-160,157,776 | $-159,672,262 |
| Other | ||||
| Ordinary Shares Number | $29,271,755 | $29,271,755 | $29,271,755 | $29,271,755 |
| Share Issued | $29,271,755 | $29,271,755 | $29,271,755 | $29,271,755 |
| Tangible Book Value | $-2,301,592 | $-1,819,230 | $-1,347,277 | $-861,863 |
| Invested Capital | $-2,301,592 | $-1,819,230 | $-1,347,277 | $-861,863 |
| Working Capital | $-2,301,592 | $-1,819,230 | $-1,347,277 | $-861,863 |
| Total Capitalization | $-2,301,592 | $-1,819,230 | $-1,347,277 | $-861,863 |
| Additional Paid In Capital | $158,789,302 | $158,781,227 | $158,781,227 | $158,781,127 |
| Capital Stock | $29,272 | $29,272 | $29,272 | $29,272 |
| Common Stock | $29,272 | $29,272 | $29,272 | $29,272 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,019,517 | $1,596,517 | $1,173,517 | $750,517 |
| Dueto Related Parties Current | $274,101 | $220,702 | $174,096 | $116,178 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-61,250 | $-46,702 | $-68,389 | $-77,772 |
| Operating Activities | ||||
| Operating Cash Flow | $-61,250 | $-46,702 | $-68,389 | $-77,772 |
| Cash Flow From Continuing Operating Activities | $-61,250 | $-46,702 | $-68,389 | $-77,772 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $8,075 | $0 | $100 | $0 |
| Financing Cash Flow | $61,474 | $46,606 | $58,018 | $49,012 |
| Cash Flow From Continuing Financing Activities | $61,474 | $46,606 | $58,018 | $49,012 |
| Net Other Financing Charges | $53,399 | $46,606 | $57,918 | $49,012 |
| Net Common Stock Issuance | $8,075 | $0 | $100 | $0 |
| Common Stock Issuance | $8,075 | $0 | $100 | $0 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $862 | $638 | $734 | $11,105 |
| Beginning Cash Position | $638 | $734 | $11,105 | $39,865 |
| Changes In Cash | $224 | $-96 | $-10,371 | $-28,760 |
| Change In Working Capital | $429,187 | $425,251 | $417,125 | $424,183 |
| Change In Payables And Accrued Expense | $429,187 | $425,251 | $417,085 | $424,223 |
| Change In Accrued Expense | $423,000 | $423,000 | $423,000 | $423,000 |
| Change In Payable | $6,187 | $2,251 | $-5,915 | $1,223 |
| Change In Account Payable | $6,187 | $2,251 | $-5,915 | $1,223 |
| Net Income From Continuing Operations | $-490,437 | $-471,953 | $-485,514 | $-501,955 |
| Change In Prepaid Assets | - | $0 | $40 | $-40 |
| Change In Other Working Capital | - | - | - | $423,000 |
| Stock Based Compensation | - | - | - | $0 |
Fetched: 2026-02-02